Vertex Pharmaceuticals Inc (VRTX)

408.18 +2.91 (+0.72%) USD  |  NASDAQ  |  Dec 24, 16:00
407.00 -1.18 (-0.29%) After-Hours: 05:43
More

Vertex Pharmaceuticals Cash and Short Term Investments (Annual): 11.22B for Dec. 31, 2023

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Eli Lilly and Co 2.928B
Gilead Sciences Inc 7.264B
Bristol-Myers Squibb Co 12.28B
Pfizer Inc 12.69B
PTC Therapeutics Inc 876.74M